US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NKGEN BIOTECH INC

0.1600

+0.024518.08%

Volume:28.63K

Turnover:4.01K

Market Cap:7.19M

PE:-0.08

High:0.1600

Open:0.1300

Low:0.1300

Close:0.1355

Loading ...

Overview Company News Filings

NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease

THOMSON REUTERS

NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease

BRIEF-NKGen Biotech Enters Seventh Amendment To Forward Purchase Agreement Dated Sept 22, 2023

NKGen Biotech Inc: Under Amendment, Co and Seller Agreed to Extend Valuation Date to Dec 31, 2025

THOMSON REUTERS

NKGen Biotech Inc - Enters Seventh Amendment to Forward Purchase Agreement Dated Sept 22, 2023

THOMSON REUTERS

BRIEF-Nkgen Biotech Selected As Preferred Stalking Horse Bidder For Nkmax Co.

NKGen Biotech: Selected as Preferred Stalking Horse Bidder for Nkmax Co., in Nkmax's Court-Managed Rehabilitation Process in South Korea

THOMSON REUTERS

NKGen Biotech Selected as Stalking Horse Bidder for NKMax

NKGen Biotech gets Nasdaq notice related to delayed quarterly report

NKGen Biotech Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel

THOMSON REUTERS

BRIEF-Nkgen Biotech Inc On Nov 5, As Part Of Cost-Reduction Efforts, Conducted A Group Layoff Of 16 Employees.

NKGen Biotech Inc: on Nov 5, as Part of \Greater Cost-Reduction Efforts, Conducted a Group Layoff of 16 Employees.

THOMSON REUTERS

BRIEF-Nkgen Biotech Says Co Placed 19 Employees On Furlough

NKGen Biotech - Co's Inability to Pay Its Payroll Obligations May Result in Employees Terminating Relationship With Co and/or Pursuing Legal Remedies

THOMSON REUTERS

NKGen Biotech Inc - on Oct 24, Co Placed 19 Employees on Furlough, Effective October 27

THOMSON REUTERS

NKGen Biotech announces presentation of two posters in AD

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17TH Annual Clinical Trials on Alzheimer’s Disease (Ctad) Conference

THOMSON REUTERS

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NKGN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NKGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NKGN\",,,,,undefined,":{"symbol":"NKGN","market":"US","secType":"STK","nameCN":"NKGEN BIOTECH INC","latestPrice":0.16,"timestamp":1745861220000,"preClose":0.1355,"halted":0,"volume":28626,"delay":15,"floatShares":22651400,"shares":44947588,"eps":-1.99872,"marketStatus":"Trading","change":0.0245,"latestTime":"04-28 13:27:00 EDT Delay","open":0.13,"high":0.16,"low":0.13,"amount":4013.75909376,"amplitude":0.221402,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.99872,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"adr":0,"exchange":"PINK","adjPreClose":0.1355,"volumeRatio":0.413706},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NKGN\",,,,,undefined,":{"symbol":"NKGN","floatShares":22651400,"roa":"-97.34%","roe":"--","lyrEps":-5.377227,"volumeRatio":0.413706,"shares":44947588,"dividePrice":0,"high":0.16,"amplitude":0.221402,"preClose":0.1355,"low":0.13,"week52Low":0.0983,"pbRate":"-0.15","week52High":2.19,"institutionHeld":0,"latestPrice":0.16,"eps":-1.99872,"divideRate":0,"volume":28626,"delay":15,"ttmEps":-1.99872,"open":0.13,"prevYearClose":0.6552,"prevWeekClose":0.1355,"prevMonthClose":0.18,"prevQuarterClose":0.18,"fiveDayClose":0.135,"twentyDayClose":0.1633,"sixtyDayClose":0.487},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NKGN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510379858","title":"NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2510379858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510379858?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:00","pubTimestamp":1739365204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA4VHFZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NKGN"],"gpt_icon":0},{"id":"2510379612","title":"NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2510379612","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510379612?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:00","pubTimestamp":1739365200,"startTime":"0","endTime":"0","summary":"The Fast Track designation accelerates troculeucel’s path to U.S. FDA submission for the treatment of patients with moderate Alzheimer’s disease.NKGen will benefit from increased FDA interactions, enhanced visibility and potential eligibility for Accelerated Approval, Priority Review, and Rolling Review of the regulatory dossier, with a faster path to market for troculeucel.SANTA ANA, Calif., Feb. 12, 2025  -- NKGen Biotech, Inc.  , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer  cell therapeutics, today announced that the U.S. Food and Drug Administration  has granted Fast Track designation for the investigation of troculeucel, ex vivo expanded autologous NK cell therapy, for the treatment of moderate Alzheimer’s disease . FDA Fast Track designation is intended to accelerate the development and review process for therapies addressing serious health conditions and unmet medical needs and off","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkgen-biotech-receives-u-fda-130000005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FAST","NKGN","BK4104","BK4588","IE00BFXG0V08.USD","BK4567","BK4585","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","NKGNW"],"gpt_icon":0},{"id":"2500183353","title":"BRIEF-NKGen Biotech Enters Seventh Amendment To Forward Purchase Agreement Dated Sept 22, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2500183353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500183353?lang=en_us&edition=fundamental","pubTime":"2025-01-03 06:36","pubTimestamp":1735857397,"startTime":"0","endTime":"0","summary":"BRIEF-NKGen Biotech Enters Seventh Amendment To Forward Purchase Agreement Dated Sept 22, 2023Jan 2  - Nkgen Biotech Inc NKGN.O:NKGEN BIOTECH INC - ENTERS SEVENTH AMENDMENT TO FORWARD PURCHASE AGREEMENT DATED SEPT 22, 2023NKGEN BIOTECH INC:  UNDER AMENDMENT, CO AND SELLER AGREED TO EXTEND VALUATION DATE TO DEC 31, 2025Source text: [ID:n0001213900-25-000418]Further company coverage: NKGN.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nFWN3NY0KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2500900895","title":"NKGen Biotech Inc:  Under Amendment, Co and Seller Agreed to Extend Valuation Date to Dec 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2500900895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500900895?lang=en_us&edition=fundamental","pubTime":"2025-01-03 05:56","pubTimestamp":1735855004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nFWN3NY0KP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2500069907","title":"NKGen Biotech Inc - Enters Seventh Amendment to Forward Purchase Agreement Dated Sept 22, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2500069907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500069907?lang=en_us&edition=fundamental","pubTime":"2025-01-03 05:56","pubTimestamp":1735855004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nFWN3NY0KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NKGN"],"gpt_icon":0},{"id":"2488986311","title":"BRIEF-Nkgen Biotech Selected As Preferred Stalking Horse Bidder For Nkmax Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2488986311","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488986311?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:16","pubTimestamp":1733174164,"startTime":"0","endTime":"0","summary":"BRIEF-Nkgen Biotech Selected As Preferred Stalking Horse Bidder For Nkmax Co.Dec 2 (Reuters) - Nkgen Biotech Inc NKGN.O:NKGEN BIOTECH: SELECTED AS PREFERRED STALKING HORSE BIDDER FOR NKMAX CO., IN NKM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2488986893","title":"NKGen Biotech: Selected as Preferred Stalking Horse Bidder for Nkmax Co., in Nkmax's Court-Managed Rehabilitation Process in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2488986893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488986893?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:14","pubTimestamp":1733174089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2488968748","title":"NKGen Biotech Selected as Stalking Horse Bidder for NKMax","url":"https://stock-news.laohu8.com/highlight/detail?id=2488968748","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488968748?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:05","pubTimestamp":1733173500,"startTime":"0","endTime":"0","summary":"Upon closing, the transaction would secure global IP rights for NKGen.NKGen and its partners can begin to commercialize troculeucel in Korea, Japan and other markets where natural-killer  cell therapy is already legal.NKGen proposal included up to $18 million in committed funding.“As we have made tremendous progress in our clinical program especially with the launch of our phase II trial for moderate stage Alzheimer’s disease, we felt that it was essential for us to preserve the very close scientific and clinical partnership with the NKMax team, rather than have NKMax acquired by someone without any cell therapy knowledge or experience”, commented Paul Y. Song, MD, Chairman and CEO of NKGen Biotech. “As we continue to work towards US FDA approval, we will be able to begin to commercialize troculeucel in countries like Japan, Thailand, Malaysia, Mexico and others where an autologous non-genetically modified cell therapy is considered as a legal treatment and already readily available. W","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GWvn3FS6iClU6MjzVvwGnA--~B/aD0xMjA7dz0zODU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/982030109771eb306c2a7df2ab73f4e9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GWvn3FS6iClU6MjzVvwGnA--~B/aD0xMjA7dz0zODU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/982030109771eb306c2a7df2ab73f4e9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkgen-biotech-selected-stalking-horse-210500152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NKGN","NKGNW"],"gpt_icon":0},{"id":"2486054832","title":"NKGen Biotech gets Nasdaq notice related to delayed quarterly report","url":"https://stock-news.laohu8.com/highlight/detail?id=2486054832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486054832?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:30","pubTimestamp":1732656620,"startTime":"0","endTime":"0","summary":"NKGen Biotech (NKGN) announced it received a notice on November 20 rom the Listing Qualifications Department of The Nasdaq Stock Market stating tha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nkgen-biotech-gets-nasdaq-notice-related-to-delayed-quarterly-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nkgen-biotech-gets-nasdaq-notice-related-to-delayed-quarterly-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","NDAQ","TQQQ","MNQmain","NQmain","BK4585","BK4112","QID",".IXIC","NKGN","LU2210149790.SGD","QLD","BK4588","PSQ","BK4139","LU2095319765.USD","LU2210150020.SGD","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2486536834","title":"NKGen Biotech Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2486536834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486536834?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:15","pubTimestamp":1732655700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUAQWTWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NDAQ","BK4585","IE00BGHQF748.EUR","BK4139","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","NKGN","NKGNW","LU2210149790.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4588"],"gpt_icon":0},{"id":"2483829067","title":"BRIEF-Nkgen Biotech Inc  On Nov 5, As Part Of Cost-Reduction Efforts, Conducted A Group Layoff Of 16 Employees.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483829067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483829067?lang=en_us&edition=fundamental","pubTime":"2024-11-13 07:33","pubTimestamp":1731454400,"startTime":"0","endTime":"0","summary":"Nov 12 (Reuters) - Nkgen Biotech Inc   :   * NKGEN BIOTECH INC:  ON NOV 5, AS PART OF \\GREATER COST-REDUCTION EFFORTS, CONDUCTED A GROUP LAYOFF OF 16 EMPLOYEES.Source text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NKGN"],"gpt_icon":0},{"id":"2483066798","title":"NKGen Biotech Inc:  on Nov 5, as Part of \\Greater Cost-Reduction Efforts, Conducted a Group Layoff of 16 Employees.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483066798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483066798?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:30","pubTimestamp":1731450638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nFWN3MJ1PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2479762939","title":"BRIEF-Nkgen Biotech Says Co Placed 19 Employees On Furlough","url":"https://stock-news.laohu8.com/highlight/detail?id=2479762939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479762939?lang=en_us&edition=fundamental","pubTime":"2024-10-31 06:04","pubTimestamp":1730325843,"startTime":"0","endTime":"0","summary":"Oct 30  - Nkgen Biotech Inc   :   * NKGEN BIOTECH INC - ON OCT 24, CO PLACED 19 EMPLOYEES ON FURLOUGH, EFFECTIVE OCTOBER 27   * NKGEN BIOTECH INC - PLANS FOR FURLOUGH TO LAST FROM OCTOBER 27 THROUGH NOVEMBER 9   * NKGEN BIOTECH - CO'S INABILITY TO PAY ITS PAYROLL OBLIGATIONS MAY RESULT IN EMPLOYEES TERMINATING RELATIONSHIP WITH CO AND/OR PURSUING LEGAL REMEDIESSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2479676183","title":"NKGen Biotech - Co's Inability to Pay Its Payroll Obligations May Result in Employees Terminating Relationship With Co and/or Pursuing Legal Remedies","url":"https://stock-news.laohu8.com/highlight/detail?id=2479676183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479676183?lang=en_us&edition=fundamental","pubTime":"2024-10-31 05:24","pubTimestamp":1730323478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61VH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2479176906","title":"NKGen Biotech Inc - on Oct 24, Co Placed 19 Employees on Furlough, Effective October 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2479176906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479176906?lang=en_us&edition=fundamental","pubTime":"2024-10-31 05:24","pubTimestamp":1730323478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2479140134","title":"NKGen Biotech announces presentation of two posters in AD","url":"https://stock-news.laohu8.com/highlight/detail?id=2479140134","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479140134?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:31","pubTimestamp":1730205070,"startTime":"0","endTime":"0","summary":"NKGen Biotech (NKGN) announced the presentation of two posters, on its first-in-kind, autologous, non-genetically modified NK cell product, trocule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nkgen-biotech-announces-presentation-of-two-posters-in-ad?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nkgen-biotech-announces-presentation-of-two-posters-in-ad?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NKGN"],"gpt_icon":0},{"id":"2479952406","title":"NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17TH Annual Clinical Trials on Alzheimer’s Disease (Ctad) Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2479952406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479952406?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:05","pubTimestamp":1730203500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUA3MVV2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NKGN","BK4139"],"gpt_icon":0},{"id":"2479409084","title":"NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2479409084","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479409084?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:05","pubTimestamp":1730203500,"startTime":"0","endTime":"0","summary":"Newly analyzed biomarker data from the initial dose-escalation Phase 1 AD trial found that troculeucel reduces GFAP, NfL, p-tau181, GDF-15, and LTBP2 levels, which are detectable up to 10 years before dementia symptoms appear according to recent reports. This suggests a potential role for the use of troculeucel in delaying or preventing dementia onset in asymptomatic individuals with detectable biomarkers.“Despite the majority of subjects receiving suboptimal dosing and only four total doses in the Phase 1 pilot trial, we found that our autologous NK cell treatment was safe and that 90% of evaluable subjects experienced stable or improved cognitive function,” said Paul Y. Song, MD, Chairman and CEO of NKGen. “We also revealed that several subjects demonstrated reductions in several neuroinflammation biomarkers, such as GFAP, NfL, p-tau181, GDF-15, and LTBP2. We believe that increased screening for these biomark","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/M_wUcWvJTgUWEOx1p0v2RQ--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/4d4a8720d597ce097de176741b8c8c1b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/M_wUcWvJTgUWEOx1p0v2RQ--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/4d4a8720d597ce097de176741b8c8c1b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkgen-biotech-presents-phase-1-120500504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NKGN","NKGNW"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NKGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-05","symbol":"NKGN","reason":null,"defaultRemindTime":1741185000000,"announcedDate":"2025-03-04","type":"delisting","dateTimestamp":1741150800000},{"market":"US","date":"2024-09-12","symbol":"NKGN","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1726113600000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-05-20","symbol":"NKGN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2024-04-16","symbol":"NKGN","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2023-11-14","symbol":"NKGN","fiscalQuarterEnding":"2023/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":-2.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NKGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NKGN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NKGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NKGN","date":"2025-03-03","current":-0.271714,"percent":0.653374,"low":-3.085872,"twenty":-1.017152,"median":-0.369534,"eighty":-0.200359,"high":-0.092159,"avg":-0.615092,"sd":0.608265,"marketCap":23979538},"quantilePoints":[{"date":"2023-10-13","current":-2.180674,"twenty":-2.944804,"median":-2.349548,"eighty":-2.292278,"marketCap":65010258},{"date":"2023-10-20","current":-2.202701,"twenty":-2.461546,"median":-2.202701,"eighty":-2.198296,"marketCap":65666928},{"date":"2023-10-27","current":-2.775403,"twenty":-2.690232,"median":-2.202701,"eighty":-2.196827,"marketCap":82740329},{"date":"2023-11-03","current":-2.239413,"twenty":-2.543386,"median":-2.202701,"eighty":-2.183611,"marketCap":66761376},{"date":"2023-11-10","current":-2.276125,"twenty":-2.411223,"median":-2.257769,"eighty":-2.196827,"marketCap":67855825},{"date":"2023-11-17","current":-2.114593,"twenty":-2.362764,"median":-2.202701,"eighty":-2.138088,"marketCap":63040250},{"date":"2023-11-24","current":-1.139241,"twenty":-2.35689,"median":-2.202701,"eighty":-2.099908,"marketCap":64134699},{"date":"2023-12-01","current":-1.341388,"twenty":-2.349548,"median":-2.188016,"eighty":-1.310321,"marketCap":75514778},{"date":"2023-12-08","current":-1.321986,"twenty":-2.334863,"median":-2.143962,"eighty":-1.283104,"marketCap":74422518},{"date":"2023-12-15","current":-1.463905,"twenty":-2.320179,"median":-2.110922,"eighty":-1.310321,"marketCap":82411994},{"date":"2023-12-22","current":-1.100359,"twenty":-2.276125,"median":-2.063931,"eighty":-1.197564,"marketCap":61945802},{"date":"2023-12-29","current":-1.193676,"twenty":-2.254098,"median":-1.734182,"eighty":-1.172679,"marketCap":67199156},{"date":"2024-01-05","current":-1.073141,"twenty":-2.239413,"median":-1.426967,"eighty":-1.161793,"marketCap":60413573},{"date":"2024-01-12","current":-1.042036,"twenty":-2.232071,"median":-1.331687,"eighty":-1.123688,"marketCap":58662455},{"date":"2024-01-19","current":-0.989545,"twenty":-2.202701,"median":-1.318097,"eighty":-1.096471,"marketCap":55707443},{"date":"2024-01-26","current":-0.913726,"twenty":-2.202701,"median":-1.312265,"eighty":-1.073141,"marketCap":51439093},{"date":"2024-02-02","current":-0.624055,"twenty":-2.202701,"median":-1.304489,"eighty":-1.065365,"marketCap":35131806},{"date":"2024-02-09","current":-0.625999,"twenty":-2.202701,"median":-1.197564,"eighty":-1.022595,"marketCap":35241251},{"date":"2024-02-16","current":-0.585173,"twenty":-2.195359,"median":-1.180067,"eighty":-0.989545,"marketCap":32942908},{"date":"2024-02-23","current":-0.388819,"twenty":-2.183611,"median":-1.166459,"eighty":-0.878514,"marketCap":21888976},{"date":"2024-03-01","current":-0.309889,"twenty":-2.157179,"median":-1.139241,"eighty":-0.629887,"marketCap":17445513},{"date":"2024-03-08","current":-0.750421,"twenty":-2.145431,"median":-1.115911,"eighty":-0.62561,"marketCap":42245723},{"date":"2024-03-15","current":-0.723204,"twenty":-2.138088,"median":-1.096471,"eighty":-0.629109,"marketCap":40713495},{"date":"2024-03-22","current":-0.863179,"twenty":-2.118998,"median":-1.079771,"eighty":-0.629887,"marketCap":48593526},{"date":"2024-03-28","current":-0.699875,"twenty":-2.110188,"median":-1.071197,"eighty":-0.63222,"marketCap":39400156},{"date":"2024-04-05","current":-0.503373,"twenty":-2.102845,"median":-1.065365,"eighty":-0.629887,"marketCap":28337889},{"date":"2024-04-12","current":-0.503373,"twenty":-2.078322,"median":-1.053701,"eighty":-0.610089,"marketCap":28337889},{"date":"2024-04-19","current":-0.338204,"twenty":-2.028247,"median":-1.022595,"eighty":-0.596449,"marketCap":19039519},{"date":"2024-04-26","current":-0.54434,"twenty":-1.680126,"median":-1.008986,"eighty":-0.567673,"marketCap":45155173},{"date":"2024-05-03","current":-0.362893,"twenty":-1.441742,"median":-0.989545,"eighty":-0.506509,"marketCap":30103448},{"date":"2024-05-10","current":-0.343649,"twenty":-1.375643,"median":-0.907894,"eighty":-0.49327,"marketCap":28507053},{"date":"2024-05-17","current":-0.320045,"twenty":-1.341404,"median":-0.877643,"eighty":-0.471192,"marketCap":26548978},{"date":"2024-05-24","current":-0.546156,"twenty":-1.329747,"median":-0.84957,"eighty":-0.471192,"marketCap":43700088},{"date":"2024-05-31","current":-0.488338,"twenty":-1.321986,"median":-0.832073,"eighty":-0.458565,"marketCap":39073844},{"date":"2024-06-07","current":-0.426129,"twenty":-1.318875,"median":-0.765974,"eighty":-0.449088,"marketCap":34096284},{"date":"2024-06-14","current":-0.410577,"twenty":-1.314209,"median":-0.762086,"eighty":-0.443054,"marketCap":32851894},{"date":"2024-06-21","current":-0.373252,"twenty":-1.314209,"median":-0.746533,"eighty":-0.419908,"marketCap":29865358},{"date":"2024-06-28","current":-0.385693,"twenty":-1.313431,"median":-0.743262,"eighty":-0.41586,"marketCap":30860870},{"date":"2024-07-05","current":-0.407466,"twenty":-1.311876,"median":-0.715734,"eighty":-0.407466,"marketCap":32603016},{"date":"2024-07-12","current":-0.323485,"twenty":-1.309543,"median":-0.686267,"eighty":-0.404316,"marketCap":25883310},{"date":"2024-07-15","current":-0.298601,"twenty":-1.308766,"median":-0.672658,"eighty":-0.402482,"marketCap":23892287},{"date":"2024-08-02","current":-0.344629,"twenty":-1.307988,"median":-0.662937,"eighty":-0.401328,"marketCap":27575111},{"date":"2024-08-09","current":-0.328524,"twenty":-1.3041,"median":-0.629887,"eighty":-0.395025,"marketCap":26286554},{"date":"2024-08-16","current":-0.281822,"twenty":-1.29088,"median":-0.625027,"eighty":-0.387569,"marketCap":22549740},{"date":"2024-08-23","current":-0.257988,"twenty":-1.23178,"median":-0.609553,"eighty":-0.372408,"marketCap":20642676},{"date":"2024-08-30","current":-0.245878,"twenty":-1.195231,"median":-0.60267,"eighty":-0.368424,"marketCap":19673682},{"date":"2024-09-06","current":-0.246103,"twenty":-1.18901,"median":-0.586145,"eighty":-0.359064,"marketCap":19691721},{"date":"2024-09-13","current":-0.280405,"twenty":-1.180456,"median":-0.583229,"eighty":-0.344629,"marketCap":22436347},{"date":"2024-09-20","current":-0.171296,"twenty":-1.176568,"median":-0.54352,"eighty":-0.33213,"marketCap":15117415},{"date":"2024-09-27","current":-0.158394,"twenty":-1.168014,"median":-0.519442,"eighty":-0.32312,"marketCap":13978747},{"date":"2024-10-04","current":-0.15587,"twenty":-1.150906,"median":-0.512641,"eighty":-0.317872,"marketCap":13755964},{"date":"2024-10-11","current":-0.115199,"twenty":-1.139241,"median":-0.503373,"eighty":-0.311624,"marketCap":10166683},{"date":"2024-10-18","current":-0.285679,"twenty":-1.139241,"median":-0.49881,"eighty":-0.304184,"marketCap":25212023},{"date":"2024-10-25","current":-0.15798,"twenty":-1.131465,"median":-0.489912,"eighty":-0.283365,"marketCap":13942248},{"date":"2024-10-31","current":-0.117128,"twenty":-1.118245,"median":-0.487643,"eighty":-0.276991,"marketCap":10336929},{"date":"2024-11-08","current":-0.110272,"twenty":-1.10969,"median":-0.473878,"eighty":-0.260707,"marketCap":9731840},{"date":"2024-11-15","current":-0.113088,"twenty":-1.099581,"median":-0.451012,"eighty":-0.251399,"marketCap":9980359},{"date":"2024-11-22","current":-0.137738,"twenty":-1.094916,"median":-0.449385,"eighty":-0.246161,"marketCap":12155796},{"date":"2024-11-29","current":-0.163245,"twenty":-1.088694,"median":-0.443706,"eighty":-0.241369,"marketCap":14406870},{"date":"2024-12-06","current":-0.183569,"twenty":-1.080918,"median":-0.426129,"eighty":-0.205158,"marketCap":16200525},{"date":"2024-12-13","current":-0.201934,"twenty":-1.078624,"median":-0.416878,"eighty":-0.201567,"marketCap":17821298},{"date":"2024-12-20","current":-0.230625,"twenty":-1.073141,"median":-0.415128,"eighty":-0.198751,"marketCap":20353306},{"date":"2024-12-27","current":-0.356731,"twenty":-1.070031,"median":-0.407466,"eighty":-0.199796,"marketCap":31482613},{"date":"2025-01-03","current":-0.282006,"twenty":-1.069253,"median":-0.405058,"eighty":-0.200963,"marketCap":24887868},{"date":"2025-01-10","current":-0.233645,"twenty":-1.067698,"median":-0.401382,"eighty":-0.201714,"marketCap":20619833},{"date":"2025-01-17","current":-0.187977,"twenty":-1.065365,"median":-0.401246,"eighty":-0.19973,"marketCap":16589511},{"date":"2025-01-24","current":-0.212259,"twenty":-1.063032,"median":-0.395025,"eighty":-0.198914,"marketCap":18732533},{"date":"2025-01-31","current":-0.248031,"twenty":-1.053701,"median":-0.388819,"eighty":-0.199649,"marketCap":21889475},{"date":"2025-02-07","current":-0.229187,"twenty":-1.051368,"median":-0.37948,"eighty":-0.199991,"marketCap":20226414},{"date":"2025-02-14","current":-0.391604,"twenty":-1.038148,"median":-0.373267,"eighty":-0.199649,"marketCap":34560200},{"date":"2025-02-21","current":-0.228168,"twenty":-1.022595,"median":-0.373252,"eighty":-0.199975,"marketCap":20136519},{"date":"2025-02-28","current":-0.272579,"twenty":-1.018707,"median":-0.369837,"eighty":-0.200057,"marketCap":24055949},{"date":"2025-03-03","current":-0.271714,"twenty":-1.017152,"median":-0.369534,"eighty":-0.200359,"marketCap":23979538}],"updateTime":1745836639642}}}